Most Contract Research Organizations (CROs) use their own data formats for standard assays, which can pose data aggregation challenges to biopharma companies. Being able to harmonize data from different CRO reports is critical to scale up absorption, distribution, metabolism, and excretion (ADME) testing of pharmacokinetics (PK) properties of drug candidates.
This case study demonstrates how TetraScience helped two clinical-stage startup companies get the most out of their CRO collaborations for ADME/PK needs.
It covers:
- The challenges of laborious manual data workflows for pharmacokinetics and pharmacodynamics (PK/PD) studies. Scientists have to manually check the reports from CROs.
- The benefits of an optimized process that connects, parses, and harmonizes ADME/PK reports from various CROs.
Harmonized data allow visualizations of structure activity relationships (SAR), data science, artificial intelligence, and machine learning (AI/ML). By automating CRO data entry, processing, and transfer, scientists save time and reduce manual errors. With automated data management, CRO outsourcing can help biopharma companies realize more cost-effective results. Read the full case study to learn more.
